EFFECT OF ORAL CLONIDINE, INSULIN-INDUCED HYPOGLYCEMIA AND EXERCISE ON PLASMA GHRH LEVELS IN SHORT-STATURE CHILDREN

Human growth hormone release is affected by a variety of pharmacological and physiological stimuli. We have studied the effect of oral clonidine, insulin hypoglycemia, and exercise on plasma hGH and GHRH levels in 31 healthy short-stature children. Thirteen underwent an oral clonidine test (0.15 mg/m2), 12 an iv. insulin test (0.1 U/kg), and 6 performed exercise (running for 10 min in a defined route). GHRH-1-44 was extracted from plasma on silica columns and determined by RIA. Although all three stimuli induced a marked increase in plasma hGH levels, only clonidine induced a significant increase in plasma GHRH levels. Maximal increment in GHRH during clonidine was 6.82 ± 1.05 pmol/l (mean ± SEM) as compared with 0.51 ± 0.28 and 0.53 ± 0.62 during hypoglycemia and exercise (p < 0.0005 and p < 0.005), respectively. An additional 24 subjects received TRH 0.2 mg/kg iv: 8 TRH alone, 8 TRH and insulin and 8 TRH and clonidine. Only insulin potentiated the TRH-induced TSH response with a peak of 22.0 ± 3.2 vs 16.0 ± 0.8 and 15.3 ± 1.5 mU/l (p < 0.025) for TRH alone and TRH and clonidine, respectively. It is suggested that clonidine stimulates hGH secretion mainly through an enhancement of GHRH release, whereas stress stimuli such as hypoglycemia and exercise achieve hGH release by a different mechanism, possibly inhibition of somatostatin.